Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD
Clinical trial NCT02525029 · COMPLETED
Trial details
- NCT number
- NCT02525029
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2021-05-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.